Credevo

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Credevo, Health/Medical/ Pharmaceuticals, Singapore.

A global Clinical Trial Organization (CTO) providing comprehensive clinical trial services for pharmaceuticals, biologics, medical devices and healthcare products Credevo provides strategic support for healthcare products including;

- Drugs

- Biologics

- Health Supplements (Nutraceuticals)

- IVD and medical devices

- Cosmetics

In areas of

- Regulatory

- Clinical Development

- Business Development Support

- Licensing (out-/in-)

- Feasibility

19/01/2026

🌟 Why a Strong Feasibility Questionnaire Matters in Clinical Trials

A well-crafted Site Feasibility Questionnaire (FQ) can prevent major delays and ensure sites are truly ready for your study.

🔬 Why feasibility matters
• Recruitment challenges account for up to 30% of clinical trial delays
• 11% of activated sites enroll zero patients
• 37% of sites underperform, slowing timelines and increasing costs

A robust FQ helps sponsors and CROs move from assumptions to evidence.

📋 What a strong FQ should evaluate
• Realistic patient access and competing studies
• Site infrastructure, staffing, and workload
• Regulatory and ethics approval timelines
• Investigator interest, availability, and commitment
• Previous performance and enrollment capability

At Credevo, we help sponsors and CROs design smarter feasibility strategies that lead to better site selection, stronger enrollment, and fewer downstream surprises.

👉 Explore the full article and download a free FQ template for deeper insights
🔗 https://tinyurl.com/2st3t5st

📩 Ready to strengthen your feasibility process and reduce trial risk?
Connect with our team here 👉 https://credevo.com/contact

🚀

16/01/2026

🔍 Key Insights From Our Ovarian Cancer Feasibility Study

Sharing key insights from our recent feasibility assessment for an ovarian cancer trial in patients with disease progression or recurrence after platinum-based chemotherapy.

📌 What We Found

• Ovarian cancer remains a major global burden with high mortality.
• Key risk factors include age, obesity, hormone replacement therapy, and family history or genetic mutations.
• Strong global research activity with 800+ ongoing trials.

📊 Recruitment Potential (avg./site/month)

🇮🇳 India: 3 | 🇵🇭 Philippines: 4 | 🇻🇳 Vietnam: 4
🇷🇺 Russia: 4 | 🇰🇷 South Korea: 2 | 🇹🇭 Thailand: 1

Promising engagement and recruitment capacity across all regions.

👉 Discover more insights: https://tinyurl.com/3b9wupyp

👉 Planning an oncology clinical trial or need feasibility support?
Connect with our experts:
🔗 https://credevo.com/contact

15/01/2026

🔬 Validating Nutraceutical Claims With Clinical Trials

As nutraceuticals continue to gain global adoption, clinical trials are essential to support health claims, ensure safety, and meet regulatory expectations.

🌱 Why Clinical Validation Matters
✔️ Builds scientific credibility
✔️ Confirms safety and efficacy
✔️ Supports global regulatory compliance

🧪 Trial Designs That Work
✔️ Randomized, double-blind, and crossover studies
✔️ Defined endpoints for benefits such as immunity and cognition

💡 The Result
Clinically tested nutraceuticals earn stronger consumer trust and stand out in a competitive market.

👉 Want to learn more about nutraceutical clinical trials?
Read the full article: https://tinyurl.com/3ncy9dyb

👉 Planning a nutraceutical clinical trial?
Connect with our experts:
🔗 https://credevo.com/contact

🌱🔬

14/01/2026

Everyone Watches the Same Molecules. Not Everyone Prepares.

13/01/2026

🚀 Early Engagement in Clinical Trials: The Key to Site Commitment and Predictable Enrollment

One of the most common challenges in clinical trials is slow site activation and inconsistent enrollment. Early engagement with sites and investigators helps build trust, improve planning, and strengthen trial ex*****on from the start.

🔍 The Cost of Poor Engagement
✔️ Delays in site activation
✔️ Budget overruns and timeline slippage
✔️ Protocol deviations and data quality risks

🏗️ What Works
✔️ Engage sites early during planning and feasibility
✔️ Co-design protocols with investigator input
✔️ Treat sites as long-term partners

📊 The Impact
✔️ Faster activation and earlier enrollment
✔️ Lower screen failure rates
✔️ More predictable trial ex*****on

At Credevo, we help sponsors implement early engagement strategies that improve site commitment and enrollment outcomes.

👉 Want deeper insights on early engagement? 📘
Read the full article: https://tinyurl.com/5hxersp2

👉 Planning a study or facing enrollment challenges?
Connect with our experts:
🔗 https://credevo.com/contact

🚀🔬

12/01/2026

🚀 PK and Statistical Methods in BA/BE Studies: Turning Complexity into Confidence

Demonstrating bioequivalence goes beyond running a study. It requires robust PK evaluation, sound statistical methods, and early strategic planning to confidently show equivalence in exposure, absorption, and performance.

🔬 PK Elements that Drive BE Decisions
✔️ AUC and Cmax for systemic exposure
✔️ Tmax, half-life, Kel, and Ka for absorption and elimination
✔️ Noncompartmental and compartmental analyses to understand drug behavior

📊 Statistical Foundations for Regulatory Acceptance
✔️ ANOVA for treatment and sequence effects
✔️ 90% confidence intervals for AUC and Cmax ratios
✔️ Mixed-effects models to manage variability
✔️ Power analysis for fit-for-purpose study design

⚠️ Common Challenges
High subject variability, crossover carryover effects, complex modeling, and evolving regulatory expectations often slow BE programs.

To support early and confident generic development, we have created a curated catalogue of ready-to-use bioequivalence study protocols for high-value products approaching loss of exclusivity between 2026 and 2030. These protocols help sponsors accelerate planning, reduce uncertainty, and identify attractive generic opportunities early.

👉 Explore our BE study protocol catalogue and plan ahead:
🔗 https://credevo.com/s/bioequivalence-study-protocol-catalogue/

👉 Facing PK, statistical, or BE study design challenges?
Connect with our experts:
🔗 https://credevo.com/contact

🚀🔬

09/01/2026

⚙️ Strategic Clinical Trial Planning: Building Success from Design to Ex*****on

Effective clinical trial planning is critical to achieving scientific rigor, regulatory alignment, and efficient study ex*****on. A well-defined strategy from early design through conduct helps minimise risk, protect participants, and ensure high-quality outcomes.

📊 Key focus areas in strategic trial planning
🔹 Clear study objectives and robust protocol design
🔹 Feasibility assessment and regulatory readiness
🔹 Strong data management and safety oversight
🔹 Optimised patient recruitment and resource allocation

At Credevo, our clinical trial experts support sponsors and research teams with strategic planning, operational insight, and end-to-end study support to help drive successful trial outcomes.

🔗 Explore the full article for detailed insights:
https://tinyurl.com/y6udrtxs

📩 Planning a clinical trial or looking to strengthen your trial strategy?
Connect with our clinical trial experts today:
👉 https://credevo.com/contact

08/01/2026

🔬 Site SOPs for Clinical Trials: A Foundation for ICH GCP Compliance

Well-written Site SOPs are essential for maintaining consistency, quality, and regulatory compliance across clinical trial operations. A structured SOP framework helps sites align daily activities with ICH GCP standards, ensuring participant safety and data integrity at every stage of the study.

💡 Key aspects of effective Site SOPs
🔹 Unified SOPs that standardise trial procedures across studies
🔹 Clear guidance for training, monitoring, and audit preparedness
🔹 Coverage of core GCP areas including protocol adherence, informed consent, safety reporting, and data management
🔹 Strong support for regulatory inspections and operational excellence

At Credevo, our medical writing team specialises in developing and reviewing Site SOPs for clinical trials, tailored to site-specific workflows while meeting global regulatory expectations. Professionally written SOPs help research teams operate with clarity, confidence, and compliance.

🔗 Explore the full article for detailed insights:
https://tinyurl.com/5y25ca97

📩 Looking to develop or enhance your Site SOPs?
Connect with our medical writing experts today:
👉 https://credevo.com/contact

07/01/2026

🌏 Nutraceutical Clinical Trials in Asia-Pacific

The Asia-Pacific nutraceutical market is growing rapidly, expected to rise from USD 110.5B in 2024 to USD 180.1B by 2029 (CAGR 10.26%). This momentum is driving strong demand for high-quality clinical evidence to support product claims and market success.

🔬 Why Nutraceutical Clinical Trials Matter
🧪 Demonstrate safety, efficacy, and optimal dosage
📑 Validate health claims with scientific evidence
🏷️ Strengthen product differentiation and credibility
🤝 Build consumer trust through data-driven outcomes

🌿 Why Asia-Pacific
👥 Diverse populations
🧑‍🔬 Skilled sites and investigators
💰 Cost-effective trial ex*****on
📈 Rapidly expanding consumer market

📊 Key Regulators
TGA | FSSAI | HSA | MFDS | MHLW

At Credevo, we help nutraceutical companies design and execute efficient clinical trials across Asia-Pacific, turning scientific insights into market-ready evidence.

👉 For more insights, read the full article:
https://tinyurl.com/45c489n8

📩 Planning a nutraceutical clinical trial? Let’s talk.
🔗 https://credevo.com/contact

06/01/2026

🌍 Country-Level Clinical Trial Feasibility: 7 Key Areas to Explore 💡

Have you considered whether your chosen country is the best fit for your clinical trial? Does it provide the necessary resources, and how does it compare with other regions?

✅ A country-level feasibility study helps evaluate the region’s readiness for successful trial ex*****on.

🔍 Key Areas to Explore:
👩‍⚕️ Patient Recruitment: Assess disease prevalence and site experience
🏛️ Regulatory & Ethics: Understand approval timelines and processes
🧑‍🔬Sites & Staff: Identify qualified teams and strong infrastructure
🎯 Incentives: Explore regulatory and financial benefits
💰 Costs & Logistics: Review project costs, shipment, and site access

💼 Structured feasibility reduces risk, improves recruitment, and ensures smoother trials.

👉 Discover more:
https://tinyurl.com/39y3d3h9

📩 Planning a global clinical trial or evaluating new countries?
Let our experts support your feasibility strategy with data-driven insights.
👉 Start the conversation today: https://credevo.com/contact

05/01/2026

🚚 Importing Ancillaries & IMPs for Clinical Trials in the Asia-Pacific 🌏

Importing Ancillaries and IMPs for clinical trials in the Asia-Pacific region involves complex challenges, including diverse regulations and the need for timely, compliant deliveries.

🔑 Key Challenges
🔹 Regulatory Complexity: Each country has distinct rules; local expertise is essential.
🔹 Documentation & Language Barriers: Accuracy in paperwork and translation avoids costly errors.
🔹 Compliance & Quality: Regular audits and coordination with authorities maintain standards.
🔹 Customs Procedures: Understanding country-specific clearance processes prevents delays.

💡 Solution
Partner with an IOR (Importer of Record) to manage documentation, compliance, and customs seamlessly, ensuring faster, risk-free imports for your clinical trials.

👉 Learn more about how IOR services simplify imports for clinical research:
https://tinyurl.com/4epca7vs

📩 Planning a clinical trial in Asia-Pacific?
Let our experts support your import strategy from start to finish. Get in touch with us today:
👉 https://credevo.com/contact

02/01/2026

🧪 Are Bioavailability and Bioequivalence Studies Essential for Nutraceuticals?

In today’s evidence-driven wellness market, bioavailability (BA) and bioequivalence (BE) studies are becoming essential to demonstrate that nutraceuticals truly deliver clinical value. Poor absorption, formulation differences, food effects, and individual variability can all significantly impact real-world efficacy.

🔍 The challenge
Many nutraceutical actives show strong in vitro potential but fail to reach meaningful systemic exposure in vivo. Without robust BA/BE data, products risk limited credibility, regulatory hurdles, and weak market differentiation.

✅ The solution
Well-designed BA/BE studies generate reliable pharmacokinetic data, support regulatory acceptance, and strengthen scientific and commercial positioning. With the right expertise, these studies can be executed efficiently without compromising data quality.

At Credevo, we support nutraceutical developers with end-to-end guidance on BA/BE study design, ex*****on, and data interpretation, helping translate science into credible claims and market confidence.

👉 Speak with our experts
https://credevo.com/contact

Read the full guide 👉 https://tinyurl.com/r848car5

Address

Singapore

Website

https://credevo.com/

Alerts

Be the first to know and let us send you an email when Credevo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

The Prenatal Consultants
101 Irrawaddy Road, #15-05/06 Royal Square Medical Centre

Want your practice to be the top-listed Clinic in Singapore?